This compound is primarily used in the synthesis of peptides and pharmaceutical intermediates. It serves as a key building block in the development of active pharmaceutical ingredients (APIs), particularly in the creation of chiral molecules. Its structure, featuring a tert-butoxycarbonyl (Boc) protecting group, makes it valuable in peptide chemistry, where selective deprotection is required. Additionally, the tetrahydro-2H-pyran-4-yl moiety contributes to its utility in designing molecules with specific steric and electronic properties, often enhancing drug bioavailability and stability. It is commonly employed in research and development for drug discovery, especially in targeting therapeutic areas such as oncology, neurology, and metabolic disorders.